Epitalon[Epithalon]
Compound snapshot
Class
Research peptide
FDA approved
No
Clinical development
Preclinical
Last reviewed
September 2026
Research areas
Immune signalling / Inflammation / Longevity research
Regulatory status
Research use only — not approved
Internet attention
Moderate
Registry query
Epitalon
A synthetic four-amino-acid peptide (Ala-Glu-Asp-Gly) based on a pineal gland extract studied in Russian gerontology since the 1980s.
Reality check — what we actually know
Supported by human evidence
- No adequately powered randomised human trials establish the outcomes this compound is marketed for.
Animal research only
- Telomerase activation and extended cell-division capacity in human fibroblast culture
- Restored melatonin rhythm and improved sleep architecture in older subjects in Russian studies
- Reported lifespan extension in rodent and fruit-fly models
Mechanistically plausible
- Reported to activate telomerase in human somatic cell culture, lengthening telomeres, and to normalise melatonin rhythm and cortisol patterns via pineal signalling.
Common internet claims
- Online discussion frequently presents Epitalon as a proven treatment rather than a research compound.
Not established
- Human efficacy for the outcomes commonly claimed
- Optimal route, quantity and duration in humans
- Long-term human safety
Evidence distribution
Each band is a live PubMed search for Epitalon, filtered to that kind of study. Top is the strongest evidence; the base is reasoning, not proof. A band with no records means that kind of study has not been published for this compound yet.
Mechanism and reported findings
Reported to activate telomerase in human somatic cell culture, lengthening telomeres, and to normalise melatonin rhythm and cortisol patterns via pineal signalling.
- Telomerase activation and extended cell-division capacity in human fibroblast culture
- Restored melatonin rhythm and improved sleep architecture in older subjects in Russian studies
- Reported lifespan extension in rodent and fruit-fly models
- Antioxidant and immune-restorative effects on the ageing thymus
Strength of the evidence: Long-running Russian longevity literature that has not been independently replicated in the West.
Safety and known cautions
Telomerase activation is the same mechanism cancers exploit — the central unresolved safety question. No Western trials.
Evidence at a glance
No single score, on purpose. The line beside each bar shows how much reported outcomes vary between studies.
Development stage
- Discovery
- PreclinicalCurrent
- Phase 1
- Phase 2
- Phase 3
- Regulatory review
- Approved